Drug approval decision times, international reference pricing and strategic launches of new drugs

Izabela Jelovac

Post-Print from HAL

Keywords: Drug launch timing; sequential launching; marketing authorization; international reference pricing (search for similar items in EconPapers)
Date: 2015-04-27
References: Add references at CitEc
Citations:

Published in Séminaire, Université Pablo de Olavide, Apr 2015, Séville, Spain

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2017)
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2015)
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2015)
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2015)
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2014)
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2014)
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2014)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:halshs-01178630

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().